Abstract Library

#4311 Characterisation of patients diagnosed with metastatic head and neck paraganglioma treated at an oncology referral institution in Colombia

Introduction: Head and neck paragangliomas (HNPGL) are rare tumours. Multiple risk factors associated with the risk of metastasis have been described, although much of the available information corresponds to the group of Pheochromocytoma and Paragangliomas, not necessarily extrapolatable to metastatic HNPGLs.

Conference:

Presenting Author: Fierro L

Authors: González A, Puerto J, Fierro L, Zarama A, Caicedo L,

Keywords: Paraganglioma, head and neck, metastasis, survival,

#3679 Ectopic Cushing's syndrome caused by a well differentiated ACTH-secreting neuroendocrine tumor of the ileum

Introduction: Ectopic Cushing syndrome is responsible for 20% of cases of Cushing’s syndrome (CS); with presentation ranging from undetectable lesions to metastatic carcinomas. Ectopic ACTH syndrome (EAS) of intestinal origin is very rare, only five patients have been reported. In this article, we report a case of an ileal ACTH-secreting Neuroendocrine tumor.

Conference:

Presenting Author:

Authors: González Devia D, Llanos-Orozco N, López-Mesa de Mesa J, Fierro-Maya L, Cuéllar-Cuéllar A,

Keywords: Ectopic ACTH syndrome, Midgut Neuroendocrine Tumor, Ectopic Cushing syndrome, Neuroendocrine Tumor, Small intestine tumor,

#1403 A Univariate Analysis of Factors Influencing Survival in Advanced Pancreatic Neuroendocrine Tumors

Introduction: Pancreatic neuroendocrine tumors (pNET) are rare and display clinical heterogeneity.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author: Jann H

Authors: Jimenez-Fonseca P, Monleón Getino A, Krug S, Fierro Maya F, Tamagno G,

Keywords: pNET, prognosis,

#992 Phase 1 and Phase 2 Clinical Trials Investigating Targets Against the Molecular Hallmarks of Gastroenteropancreatic Neuroendocrine Tumors

Introduction: Recently there have been many advances in the diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors (GEP NETs), accompanied by significant improvements in our understanding of GEP NET biology. A number of well-established or novel molecular hallmarks are involved in GEP NET tumorigenesis and may help in identifying potential diagnostic or therapeutic targets.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Tamagno G

Authors: Tamagno G, Crespo G, Fierro Maya F, Fossmark R, Igaz P,

Keywords: neuroendocrine tumor, clinical trial, hallmark,